Orcimed Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Orcimed Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2022-02-24 Hyderabad, Telangana Active Unlisted
Share
OL Orcimed Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Orcimed Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
69/100
Trust Score
Moderate

Orcimed Life Sciences Private Limited is assessed as Moderate with a Trust Score of 69/100. Orcimed Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2022, operating in the Life Sciences sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Orcimed Life Sciences Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
69/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 1 satisfied (5.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
KRANTHI KUMAR CHINTALA 01234567 Director 01/04/2018 6 yrs Approved
SUMANCHANDRA MAARISETTY 01234567 Director 01/04/2018 6 yrs Approved
AGRELLA JR CHARLES DAVID 01234567 Director 01/04/2018 6 yrs Approved
SOMESHWAR KOMURAVELLI 01234567 Director 01/04/2018 6 yrs Approved
Saleha Fatima Quadri 01234567 Director 01/04/2018 6 yrs Approved
Apurva Srigiri 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: SUMANCHANDRA MAARISETTY (CEO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (4 years).
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view21/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
20 May 2025
Charge satisfied
Canara Bank
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Dec 2023
Director ceased
KRANTHI KUMAR CHINTALA
Director ceased
AGRELLA JR CHARLES DAVID
08 Mar 2023
Charge created
Canara Bank - 5.00 cr
01 Sep 2022
Director appointed
AGRELLA JR CHARLES DAVID (Director)
11 Jul 2022
Director appointed
KRANTHI KUMAR CHINTALA (Director)
02 May 2022
Director appointed
SUMANCHANDRA MAARISETTY (CEO)
24 Feb 2022
Incorporated
Registered with Roc Hyderabad
Director appointed
SOMESHWAR KOMURAVELLI (Director)
Director appointed
Saleha Fatima Quadri (Director)
Director appointed
Apurva Srigiri (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Saltinc Consulting Private Limited U72900MH2022PTC394938 Mumbai, Maharashtra, India
Fractal U72900MH2018PTC318795 Mumbai, Maharashtra, India
Smb Hosting Solutions U74999TN2017PTC116797 Chennai, Tamil Nadu, India
Dynamic Execution (Opc) Private Limited U74999WB2017OPC222707 Kolkata, West Bengal, India
Phantez Tech Private Limited U72900TG2020PTC146428 Hyderabad, Telangana, India
Teamforce Infrastructure Private Limited U72900KL2020PTC065414 Pathanamthitta, Kerala, India
Maplebell Private Limited U72900KA2022PTC160770 Bangalore North, Karnataka, India
Aikon Infocom Private Limited U72200DL2001PTC110284 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Orcimed Life Sciences Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Orcimed Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Orcimed Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 69/100, distress signals and MSME payment-delay disclosures - know whether Orcimed Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Orcimed Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Orcimed Life Sciences Private Limited an active company?

Orcimed Life Sciences Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Orcimed Life Sciences Private Limited financially healthy?

Orcimed Life Sciences Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Orcimed Life Sciences Private Limited?

Its overall Trust Score is 69/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Orcimed Life Sciences Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 6 active director(s) are on record.

Does Orcimed Life Sciences Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Orcimed Life Sciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Orcimed Life Sciences Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.